Delivery Order SPE2DB22D1106-SPE2DB25FEXC5
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, a medication used to treat certain types of hyperparathyroidism. The firm-fixed-price contract has a ceiling value of $4,689.54 and is set to expire on January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Cinacalcet HCl 30 mg tablets. The $4,260.99 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 8, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, with a ceiling value of $9,227.61 and a completion date of July 10, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cinacalcet HCl 30 mg tablets. The contract has a ceiling value of $2,649.80 and a completion date of July 10, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $19,581.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of cinacalcet hydrochloride 30 mg tablets, a medication used to treat certain types of hyperparathyroidism. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,733.29 fixed-price contract is for the delivery of Cinacalcet HCL 30 mg tablets. The contract has an ultimate completion date of April 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,522.07 firm fixed-price delivery order is for the supply of 4,560,425,714 units of the drug Cinacalcet HCl 30 mg tablets. The contract has an ultimate completion date of March 30, 2023 and was awarded on March 29, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4558010490 - CINACALCET HCL 30 MG TABLET 30S, with a ceiling value of $1,439.81. The contract is a firm fixed-price delivery order, with an ultimate completion date of August 8, 2022. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award is a delivery order worth $1,161.90 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Cinacalcet HCL 30 mg tablets and has a completion date of February 3, 2025. The contract is not designated as a set-aside and is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CINACALCET HCL 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,201.58 and a completion date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXC5Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, a medication used to treat certain types of hyperparathyroidism. The contract has a firm fixed price of $3,123.92 and a performance period ending on July 10, 2025. This appears to be a non-set-aside contract, meaning it was open to full and open competition. Amerisourcebergen Drug Corp is the prime contractor and does not have any listed subcontractors. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/9/25 |